and had been infringed by Parse's use of ATAC-seq methods and compositions. Meanwhile, litigation regarding Parse’s gene expression products remains ongoing, with several patents under appeal.

“We are pleased with this resolution on ATAC as we continue to defend the asserted Brenner patents on appeal.” The company’s litigation against Parse’s gene expression products remains ...

They also used single-cell ATAC-Seq to examine differences in gene regulation patterns between bone-marrow derived cells at various stages of differentiation, from hematopoietic stem cells to ...

A recent study has shed light on the transcriptional regulatory mechanisms of Penicillium expansum, the fungal culprit behind ...

"We are pleased with this resolution on ATAC as we continue to defend the asserted Brenner patents on appeal." The company's litigation against Parse's gene expression products remains ongoing ...